UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Switching to Raltegravir From a Virologically Effective Boosted Protease Inhibitor Regimen: A Comparative Effectiveness Analysis From the French Hospital Database on HIV (FHDH-ANRS CO4)

Clinical infectious diseases, 2016-11, Vol.63 (9), p.1254-1261

2016

Volltextzugriff (PDF)

Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice

PloS one, 2015-12, Vol.10 (12), p.e0144746-e0144746

2015

Volltextzugriff (PDF)

Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status

EBioMedicine, 2017-08, Vol.22 (C), p.122-132

2017

Volltextzugriff (PDF)

Polymorphism of gp41 glycoprotein might influence the progression to disease in HIV-1 infection

AIDS (London), 2013-04, Vol.27 (7), p.1189-1191

2013

Volltextzugriff (PDF)

Anticardiolipin Antibodies in HIV Infection Are Independently Associated with Antibodies to the Membrane Proximal External Region of gp41 and with Cell-Associated HIV DNA and Immune Activation

Clinical infectious diseases, 2009-01, Vol.48 (1), p.123-132

2009

Volltextzugriff (PDF)

Better health-related quality of life after switching from a virologically effective regimen to a regimen containing efavirenz or nevirapine

AIDS care, 2010-01, Vol.22 (1), p.54-61

2010

Volltextzugriff (PDF)

Lopinavir/r no longer recommended as a first‐line regimen: a comparative effectiveness analysis

Journal of the International AIDS Society, 2014-01, Vol.17 (1), p.19070-n/a

2014

Volltextzugriff (PDF)

Contraceptive use in HIV-positive women

Journal of acquired immune deficiency syndromes (1999), 2004-06, Vol.36 (2), p.714-720

2004

Volltextzugriff (PDF)

HIV Infection and Long-Term Residual Cardiovascular Risk After Acute Coronary Syndrome

Journal of the American Heart Association, 2020-09, Vol.9 (17), p.e017578

2020

Volltextzugriff (PDF)

Trends in post-infection CD4 cell counts and plasma HIV-1 RNA levels in HIV-1-infected patients in France between 1997 and 2005

Journal of acquired immune deficiency syndromes (1999), 2009-11, Vol.52 (3), p.422-426

2009

Volltextzugriff (PDF)

Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4)

International journal of epidemiology, 2014-10, Vol.43 (5), p.1425-1436

2014

Volltextzugriff (PDF)

First-line highly active antiretroviral regimens in 2001-2002 in the French Hospital Database on HIV : combination prescribed and biological outcomes

Antiviral therapy, 2007-01, Vol.12 (3), p.317-324

2007

Volltextzugriff (PDF)

Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma‐derived FVIII or FIX concentrate: results from the French haemophilia cohort

British journal of haematology, 2002-02, Vol.116 (2), p.383-389

2002

Volltextzugriff (PDF)

Impact of newly available drugs on clinical progression in patients with virological failure after exposure to three classes of antiretrovirals

Antiviral therapy, 2005-01, Vol.10 (4), p.563-573

2005

Volltextzugriff (PDF)

Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort

AIDS (London), 2014-09, Vol.28 (14), p.2109-2118

2014

Volltextzugriff (PDF)

Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal

Clinical infectious diseases, 2009-04, Vol.48 (8), p.1138-1151

2009

Volltextzugriff (PDF)

Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4

Archives of internal medicine (1960), 2010-07, Vol.170 (14), p.1228

2010

Volltextzugriff (PDF)

HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years

AIDS (London), 2010-03, Vol.24 (5), p.763-771

2010

Volltextzugriff (PDF)

How does loss to follow‐up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificates

HIV medicine, 2009-04, Vol.10 (4), p.236-245

2009

Volltextzugriff (PDF)

Interleukine-2 Therapy Does Not Increase the Risk of Hodgkin or Non-Hodgkin Lymphoma in HIV-Infected Patients: Results From FHDH ANRS CO4

Journal of acquired immune deficiency syndromes (1999), 2009-02, Vol.50 (2), p.206-214, Article 206

2009

Volltextzugriff (PDF)

Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl

AIDS (London), 2009-09, Vol.23 (15), p.1997-2004

2009

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Switching to Raltegravir From a Virologically Effective Boosted Protease Inhibitor Regimen: A Comparative Effectiveness Analysis From the French Hospital Database on HIV (FHDH-ANRS CO4)

Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice

Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study

Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status

Polymorphism of gp41 glycoprotein might influence the progression to disease in HIV-1 infection

Anticardiolipin Antibodies in HIV Infection Are Independently Associated with Antibodies to the Membrane Proximal External Region of gp41 and with Cell-Associated HIV DNA and Immune Activation

Better health-related quality of life after switching from a virologically effective regimen to a regimen containing efavirenz or nevirapine

Lopinavir/r no longer recommended as a first‐line regimen: a comparative effectiveness analysis

Contraceptive use in HIV-positive women

HIV Infection and Long-Term Residual Cardiovascular Risk After Acute Coronary Syndrome

Trends in post-infection CD4 cell counts and plasma HIV-1 RNA levels in HIV-1-infected patients in France between 1997 and 2005

Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4)

First-line highly active antiretroviral regimens in 2001-2002 in the French Hospital Database on HIV : combination prescribed and biological outcomes

Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma‐derived FVIII or FIX concentrate: results from the French haemophilia cohort

Impact of newly available drugs on clinical progression in patients with virological failure after exposure to three classes of antiretrovirals

Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort

Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal

Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4

HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years

How does loss to follow‐up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificates

Interleukine-2 Therapy Does Not Increase the Risk of Hodgkin or Non-Hodgkin Lymphoma in HIV-Infected Patients: Results From FHDH ANRS CO4

Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl

Aktive Filter

Suchergebnisse filtern